XNIF:LSE:LSE-Xtrackers Nifty 50 Swap UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 19536

Change

0.00 (0.00)%

Market Cap

USD 0.19B

Volume

213.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
XNIF:LSE
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.05 (+2.20%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.46%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.12 (+0.65%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+2.98 (+2.82%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.80 (-2.46%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.13 (+0.43%)

USD 259.48B
0QZO:LSE 0QZO

N/A

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.00 (+0.69%)

USD 202.26B
0R24:LSE Intel Corp.

-1.08 (-5.12%)

USD 196.14B

ETFs Containing XNIF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.47% 39% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.47% 39% F 45% F
Trailing 12 Months  
Capital Gain -5.58% 28% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.58% 27% F 41% F
Trailing 5 Years  
Capital Gain 104.83% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 104.83% 88% B+ 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.89% 81% B- 80% B-
Dividend Return 15.89% 81% B- 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.59% 50% F 69% C-
Risk Adjusted Return 116.89% 95% A 97% N/A
Market Capitalization 0.19B 60% D- 34% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike